clinical applications programming package 5 (Siemens AG)
90
Structured Review
Siemens AG
clinical applications programming package 5
Clinical Applications Programming Package 5, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pass+software+package+program/clinical+applications+programming+package+software/pm15129185-66-8-13
Average 90 stars, based on 1 article reviews
Clinical Applications Programming Package 5, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pass+software+package+program/clinical+applications+programming+package+software/pm15129185-66-8-13
Average 90 stars, based on 1 article reviews
clinical applications programming package 5 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma Article Snippet: Purpose: To evaluate 3¶-deoxy-3¶-[F]fluorothymidine-positron emission tomography (FLT-PET) for early monitoring response of high-grade non-Hodgkin’s lymphoma to treatment with cyclophosphamide-adriamycin-vincristine-prednisone chemotherapy with or without rituximab immunotherapy (R-CHOP/CHOP).. Experimental Design: Twenty-two patients with histologically proven high-grade nonHodgkin’s lymphoma scheduled to undergo first line treatment with R-CHOP/CHOP were included.. All patients received baseline imaging before therapy with FLT-PET. Article Title: In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta. Article Snippet: A region of interest analysis was performed with Clinical Applications Programming Package 5 ( Software:Article Title: Syntheses, structures, and fluxionality of blue luminescent zinc(II) complexes: Zn(2,2',2"-tpa)Cl2, Zn(2,2',2"-tpa)2(O2CCF3)2, and Zn(2,2',3"-tpa)4(O2CCF3)2 (tpa = tripyridylamine). Article Snippet: Three novel Zn(II) complexes containing either 2,2′,2′′-tripyridylamine (2,2′,2′′-tpa) or 2,2′,3′′-tripyridylamine (2,2′,3′′-tpa) have been synthesized and structurally characterized.. Compound 1, Zn(2,2′,2′′-tpa)Cl2, has a tetrahedral geometry while compounds 2, Zn(2,2′,2′′-tpa)2(O2CCF3)2, and 3, Zn(2,2′,3′′-tpa)4(O2CCF3)2, have an octahedral geometry.. The 2,2′,2′′-tpa ligand in 1 and 2 functions as a bidentate ligand, chelating to the zinc center, while the 2,2′′,3′′-tpa ligand in 3 functions as a terminal ligand, binding to the zinc center through the 3-pyridyl nitrogen atom. Article Title: Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function. Article Snippet: a Department of Psychiatry, University Medical Center Groningen (UMCG), P.O.. Box 30.001, 9700 RB Groningen, The Netherlands b Psychiatric Hospital GGZ Drenthe, P.O.. Box 30007, 9400 RA Assen, The Netherlands c Department of Nuclear Medicine and Molecular Imaging, UMCG, Groningen, The Netherlands d Department of Neurology, UMCG, Groningen, The Netherlands e Department of Nuclear Medicine and PET Research, VU Medical Center, P.O. Article Title: Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood–brain barrier Article Snippet: .. In addition, a whole brain ROI was manually drawn using Positron Emission Tomography:Article Title: Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function. Article Snippet: a Department of Psychiatry, University Medical Center Groningen (UMCG), P.O.. Box 30.001, 9700 RB Groningen, The Netherlands b Psychiatric Hospital GGZ Drenthe, P.O.. Box 30007, 9400 RA Assen, The Netherlands c Department of Nuclear Medicine and Molecular Imaging, UMCG, Groningen, The Netherlands d Department of Neurology, UMCG, Groningen, The Netherlands e Department of Nuclear Medicine and PET Research, VU Medical Center, P.O. Article Title: Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood–brain barrier Article Snippet: .. In addition, a whole brain ROI was manually drawn using |